Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

10/1/2012 (2 years ago)

Catholic Online (www.catholic.org)

Costly drug Herceptin successfully lessens cancer risk at a $70,000 price tag

According to a final analysis of the Phase III HERA trial, pharmaceutical company Roche and the Breast International Group, patients in early-stage HER2-positive breast cancer should remain on Herceptin treatment for one year, and not two years or six months. The drug has been found to be tremendously beneficial - but at a very high cost, that puts it out of reach for many.

A full one-year course of Herceptin treatment costs a whopping $70,000. According to various media sources, Genentech has never explained why the drug is so expensive.

A full one-year course of Herceptin treatment costs a whopping $70,000. According to various media sources, Genentech has never explained why the drug is so expensive.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

10/1/2012 (2 years ago)

Published in Health

Keywords: Breast cancer, Herceptin, cost, socialized medicine


LOS ANGELES, CA (Catholic Online) - A breast cancer blockbuster medication, Herceptin had sales last year of $5.5 billion. Approximately one quarter of patients with breast cancer tumors which generate HER2, a protein which makes the disease much more aggressive and are treated with Herceptin.

The latest data from the Phase III HERA trial demonstrated that two years of treatment on Herceptin made no difference to patients' disease-free survival times, which is how long women recovered without the cancer being regenerated.

Followed up for an average of eight years, the trial showed that disease-free survival improvements and overall survival for those on Herceptin was statistically significant than those without. Roche added that "there were no safety findings in the trial."

"Herceptin has changed the lives of many people with HER2-positive early breast cancer by increasing their chance of cure. HERA is one of the largest and longest-running breast cancer trials and demonstrates our commitment to people with this aggressive disease," Hal Barron, M.D., Roche's Chief Medical Officer and Head of Global Product Development, said.

"These results answer an important question and support current medical practice, where Herceptin treatment for one year is recommended and approved for people with early-stage HER2-positive breast cancer."

Dr. Martine Piccart, Chair of Breast International Group, added "It's essential that our clinical trials help us understand just how long patients need to receive a particular treatment. These results give us both the evidence and the reassurance that it's not necessary to give patients with early-stage HER2-positive breast cancer Herceptin for more than one year."

A full one-year course of Herceptin treatment costs a whopping $70,000. According to various media sources, Genentech has never explained why the drug is so expensive.

Australia has managed to knock the price down to $50,000. Several countries with universal health care, including the U.K., have had problems regarding price and including full Herceptin usage for breast cancer patients. In the U.K., the National Health Service pays for cancer medication -- patients get them free if they have been approved for payment by NICE, the National Institute for Clinical Excellence. If not, the patient has to pay.

Cancer patients and advocacy groups from Ontario, Canada, eventually managed, after going to the highest levels in the courts, to get the Ontario Ministry of Health in July 2005 to agree to pay for Herceptin treatment.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for July 2015
Universal:
That political responsibility may be lived at all levels as a high form of charity.
Evangelization: That, amid social inequalities, Latin American Christians may bear witness to love for the poor and contribute to a more fraternal society.



Comments


More Health

Heart pump, size of a golf ball, could change lives of millions of patients Watch

Image of

By Catholic Online (NEWS CONSORTIUM)

Retired father-of-three, 63-year-old Harry Chivers suffered a heart attack last year. His health failing, he anxiously awaited for a possible heart transplant when he was offered the chance to become a pioneer in heart health research. Fitted with a heart pump ... continue reading


Do you know what a can of Coke really does to your body? Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Although Coke and sodas are a favorite for people all over the world, sodas are something that slowly changes our health and can lead into a number of diseases from the high amount of processed sugar. Starting from the first 10 minutes after a can of Coke is consumed, ... continue reading


Discovery of five different kinds of prostate cancer heralded as breakthrough Watch

Image of While many men have prostate cancer, it can grow so slowly it might not cause any problems until the patient eventually dies of something else.

By Catholic Online (NEWS CONSORTIUM)

Scientists in the United Kingdom have discovered the most common cancer among men can be classified into five types, depending on its DNA. This is a breakthrough in prostate cancer research, and once the type of cancer is identified, the patient's survival rate ... continue reading


8-year-old boy becomes youngest double-hand transplant patient Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

Surgeons believe 8-year-old Zion Harvey is the youngest to receive a double-hand transplant. The boy lost both of his hands over a severe infection years ago and opted to go through a transplant with the support of his parents. After the initial success of the ... continue reading


World's first malaria vaccine wins approval from European drug regulators Watch

Image of Mosquirix must first win agreement from African governments as the vaccine only offers only partial protection.

By Catholic Online (NEWS CONSORTIUM)

The world's first malaria vaccine is a go with European drug regulators after it was recommended safe and effective for babies at risk of the 'mosquito-born disease' in Africa. LOS ANGELES, CA (Catholic Online) - Called Mosquirix, the vaccine was developed by ... continue reading


560-pound man sets out to bike across the U.S. to lose weight and save his marriage Watch

Image of [Photo by: ABC News]

By Talia Ramos (NEWS CONSORTIUM)

To try to live a healthy life, get a job and save his failing marriage, a 560-pound man decided to embark on a biking journey across the United States. He has already traveled about 90 miles since he started last month and has lost around 60 pounds during the first two ... continue reading


Catholic organization's approach to female reproductive health a 'game changer' Watch

Image of Together with his colleagues, Dr. Thomas Hilgers developed NaPro (Natural Procreative) Technology. In Omaha in 1985, they founded the Pope Paul VI Institute for the Study of Human Reproduction, and in 1999 formally created the Creighton Model FertilityCare System.

By Gabrielle Cubera, CNA EWTN News

With the hope of providing authentic and ethical health care for women, Dr. Thomas Hilgers, creator of Natural Procreative Technology, has worked for decades to establish a medical network that studies, understands, and treats the female fertility cycle. Omaha, ... continue reading


Have scientists found the key to shut off aging? New study with worms finds success Watch

Image of

By Nikky Andres (NEWS CONSORTIUM)

Scientists have uncovered how to switch off the aging process, during a recent study with worms, which could possibly lead to the process being successful in humans. MUNTINLUPA, PHILIPPINES (Catholic Online) - The new study showed that adult cells of worms shortly ... continue reading


New eye drops may soon replace cataract surgery Watch

Image of Vision could cease altogether if cataracts remain untreated. Cataracts cause more blindness worldwide than any other eye condition.

By Catholic Online (NEWS CONSORTIUM)

Inexpensive and easy to administer, a new eye drop may soon make cataract removal surgery obsolete. A frequent bane of existence that afflicts the elderly, the new drops dissolves the clumps of protein that clouds vision. LOS ANGELES, CA (Catholic Online) - Cataract ... continue reading


Superhero DNA desired by pharmaceutical researchers for new drugs Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

They don't have the ability to fly or come with laser eyes, but there are people who exist today with the "superhero" genes. Similar to the figures portrayed in media, these people have ordinary lives with extraordinary physical abilities because of uncommon biological ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Exodus 16:2-4, 12-15
2 And the whole community of Israelites began ... Read More

Psalm, Psalms 78:3-4, 23-24, 25, 54
3 What we have heard and know, what our ancestors ... Read More

Gospel, John 6:24-35
24 When the people saw that neither Jesus nor his ... Read More

Reading 2, Ephesians 4:17, 20-24
17 So this I say to you and attest to you in the ... Read More

Saint of the Day

Saint of the Day for August 2nd, 2015 Image

St. Eusebius of Vercelli
August 2: Christians who breathed a sigh of relief when Constantine ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter